Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
-
Amarin (AMRN) Shares Sink as Analyst Sees Delay to Marine Patent Issue
-
Canaccord Genuity Reiterates a 'Buy' on Amarin (AMRN); Q2/11: Outcomes Trial SPA Set, IP, BD Advances by Mid-2012
-
Canaccord Genuity Reiterates a 'Buy' on Amarin (AMRN); Attractive Entry Point
-
Canaccord Genuity Reiterates a 'Buy' on Amarin (AMRN); Raising PT on Strong MARINE Data Detail at NLA
-
Canaccord Genuity Reiterates a 'Buy' on Amarin (AMRN); Q1/11: AMR101 "MARINE" NDA on Track in Q3
-
Canaccord Genuity Reiterates a 'Buy' on Amarin Corp (AMRN); Anchor Data Drops and Crushes It
-
Canaccord Genuity Reiterates a 'Buy' on Amarin (AMRN); AMR101, Lovaza and LDL at ACC: Does (Particle) Size Matter?
-
Canaccord Genuity Reiterates a 'Buy' on Amarin (AMRN); Q4/10: ANCHOR Data on Track for April/May
-
Canaccord Genuity Reiterates a 'Buy' on Amarin Corporation (AMRN); ANCHOR Preview: Past EPA/statin Trials Show Good TG Reduction
-
Canaccord Genuity Reiterates a 'Buy' on Amarin Corp (AMRN), Citing High Chance of ANCHOR Success, AMR 101 Market Potential
-
Canaccord Genuity Reiterates a 'Buy' on Amarin Corporation (AMRN); Clinical, IP, Market Takeaways From Call With AMRN Management;
-
Canaccord Genuity reiterates a 'Buy' on Amarin (AMRN) on Sales Estimates for Hypertriglyceridemia
-
Amarin Corp. (AMRN) Intends ADS Offering
-
Canaccord Genuity on Life Sciences/Biotechnology: BEST IDEAS FOR 2011: AMRN, DNDN, FOLD, NPSP, OREX, VRUS
-
Canaccord Genuity reiterates a 'Buy' on Amarin Corp (AMRN); MARINE Data Bodes Well for Q2/11 ANCHOR Data
-
Canaccord Genuity Maintains a 'Buy' on Amarin (AMRN); Additional JELIS Sub-analysis Supports Promise of AMR101
-
Canaccord Genuity Starts Amarin Corporation (AMRN) at Buy
